Time to Continuous Renal Replacement Therapy Initiation and 90-Day Major Adverse Kidney Events in Children and Young

Katja M Gist1, Shina Menon2, Pilar Anton-Martin3

  • 1Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio.

JAMA Network Open
|January 2, 2024
PubMed

Insights

Delaying continuous renal replacement therapy (CRRT) in children and young adults with acute kidney injury increases the risk of major adverse kidney events (MAKE-90), including mortality. Further research is needed to optimize CRRT timing.

Area of Science:

  • Pediatric Nephrology
  • Critical Care Medicine
  • Renal Replacement Therapy

Background:

  • Early continuous renal replacement therapy (CRRT) initiation in adults with acute kidney injury or volume overload has not shown survival benefits.
  • The impact of CRRT initiation timing on outcomes in pediatric and young adult populations remains unknown.

Purpose of the Study:

  • To investigate the association between CRRT initiation timing and major adverse kidney events at 90 days (MAKE-90) in children and young adults.
  • To explore the role of volume overload (VO) in this association.

Main Methods:

  • Multinational retrospective cohort study using the WE-ROCK registry (2015-2021).
  • Included 969 patients (birth to 25 years) receiving CRRT for acute kidney injury or VO.
  • Primary exposure: time from ICU admission to CRRT initiation. Primary outcome: MAKE-90 (death, dialysis dependence, or persistent kidney dysfunction).

Main Results:

  • MAKE-90 occurred in 65.0% of patients; mortality was 58.4% among those with MAKE-90.
  • Longer time to CRRT initiation was associated with a higher risk of MAKE-90 (median 3 days vs 2 days; P=.002).
  • Each 1-day delay in CRRT initiation was associated with approximately 3% higher odds of MAKE-90 (OR, 1.03; 95% CI, 1.02-1.04).

Conclusions:

  • Delayed CRRT initiation in children and young adults is linked to an increased risk of MAKE-90, particularly mortality.
  • Findings highlight the need for prospective studies to determine optimal CRRT timing and its interaction with volume overload in this population.
  • Optimizing CRRT initiation timing may improve survival and reduce morbidity in pediatric patients with acute kidney injury.
Abstract

Related Concept Videos

Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
94
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
95
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
320
Renal Drug Clearance: Overview01:06

Renal Drug Clearance: Overview

Renal clearance is a crucial parameter in pharmacokinetics that quantifies the rate at which the kidneys excrete a drug. It represents a constant fraction of the central volume of distribution containing the drug that the kidney eliminates per unit of time.
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
207
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
63